Adjuvia Therapeutics, a biotechnology company developing therapeutics to treat mitochondrial dysfunction and disease, announced the closing of an $8 million Series Seed financing. The round was led by JLO Ventures, with participation from Portfolia Ventures and experienced biopharmaceutical industry leaders.